Of note, these young IL-10 KO mice do not develop colitis despite the administration of DNBS, so we assess the biological efficacy of these recombinant bacteria on a well characterized low-grade intestinal inflammation model (Martín et al., 2014; Allain et al., 2016). This evidence concerns the gene IL10 and gastroenteritis.